EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Pulsed Field Ablation for Atrial Fibrillation in Patients With Obesity: Procedural and Clinical Outcomes

Francis J Ha iD, Duron Prinsloo iD, Edwin Xu, Hui Chen Han, Nitesh Nerlekar, Adam J Brown, Emily Kotschet

Pacing and Clinical Electrophysiology · 2026

DOI: 10.1111/pace.70145 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Pacing and Clinical Electrophysiology, 2026. Verfasst von Francis J Ha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Victorian Heart Institute and Victorian Heart Hospital, Monash University, Clayton, Victoria, Australia. Hauptthemen laut MEDLINE: Atrial Fibrillation, Obesity, Catheter Ablation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Procedural and clinical outcomes in patients with obesity undergoing catheter ablation for atrial fibrillation (AF) have been mixed. Clinical data in the context of pulsed field ablation (PFA) are currently limited in this patient cohort.

Methods

We conducted an observational study of consecutive patients undergoing PFA with a pentaspline catheter (Farapulse TM , Boston Scientific) for AF at a tertiary center comparing procedural and clinical outcomes in patients with body mass index (BMI) 30 s at any follow‐up.

Results

537 (95%) out of 564 consecutive patients underwent de novo PFA for AF between 2022 and 2025 with a recorded BMI; 326 (60.7%) were nonobese, 117 (21.8%) were obese and 94 (17.5%) morbidly obese patients. Proportion of females increased according to BMI ( p = 0.003). Obesity correlated with CHA 2 DS 2 ‐VASc score, hypertension, diabetes mellitus, obstructive sleep apnea and heart failure with reduced ejection fraction ( p < 0.05 for all). Persistent AF was more common ( p = 0.048). Radiation exposure was significantly increased in obese patients ( p < 0.001). There was no difference in major (1.2%–3.2%) or minor (11%–15%) procedural complications between groups. There was no difference in freedom from arrhythmia recurrence between groups (67%–70% at median follow‐up 5.9–7.4 months).

Conclusion

Patients with obesity had no signal of increased risk detected with regard to procedural safety and clinical outcomes with PFA for AF compared with nonobese patients. These findings apply to a specific pentaspline PFA catheter rather than PFA technology in general.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationObesityCatheter AblationHumansFemaleMaleTreatment OutcomeMiddle AgedAged

Stichwörter der Autor:innen

atrial fibrillationobesitypulsed field ablation

Autor:innen und Institutionen

  • Victorian Heart Institute and Victorian Heart Hospital, Monash University, Clayton, Victoria, Australia.

ORCID-Profile: Francis J Ha, Duron Prinsloo

Zitieren

APA

Ha, F. J., Prinsloo, D., Xu, E., Han, H. C., Nerlekar, N., Brown, A. J., & Kotschet, E. (2026). Pulsed Field Ablation for Atrial Fibrillation in Patients With Obesity: Procedural and Clinical Outcomes. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70145

Vancouver

Ha FJ, Prinsloo D, Xu E, Han HC, Nerlekar N, Brown AJ, et al. Pulsed Field Ablation for Atrial Fibrillation in Patients With Obesity: Procedural and Clinical Outcomes. Pacing and Clinical Electrophysiology. 2026. doi:10.1111/pace.70145

BibTeX
@article{Ha2026,
  author = {Ha, Francis J and Prinsloo, Duron and Xu, Edwin and Han, Hui Chen and Nerlekar, Nitesh and Brown, Adam J and Kotschet, Emily},
  title = {Pulsed Field Ablation for Atrial Fibrillation in Patients With Obesity: Procedural and Clinical Outcomes},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2026},
  doi = {10.1111/pace.70145}
}
Kostenlos starten →